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Abstract:
Vitamin D (specifically vitamin D3) is a lipid soluble essential nutrient. It is found in few foods
naturally but can be synthesized upon skin exposure to sunlight. Its intermediate structure in the
blood is serum 25-hydroxyvitamin D, also called calcidiol, and is formed in the liver. Vitamin D
receptors have been found in numerous areas of the brain that are involved in mood-related
hormone production. It has also been found to be protective against the brain degradation of
Alzheimer’s. Numerous studies have found a significant relationship between vitamin D and
major depressive disorder. This review summarizes research on the connection between vitamin
D and postpartum depression. Research indicates that vitamin D is likely to be an influential
factor in the development and/or severity of postpartum depression. However, more studies are
needed to confirm the findings. Preventative screening for deficiencies and encouraging prenatal
supplementation could be simple and effective ways to possibly protect from postpartum
depression.
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Introduction:
A number of studies have investigated the role and mechanism of various nutrients in the
development of neurological diseases1. More recently, in an attempt to understand the
complexity of mood disorders in postpartum women, studies have begun to research the role of
diet in their development2. Specifically, regarding postpartum depression, some key risky
exposures that have been identified include BMI, and personal history of pre-pregnancy and
antenatal depression. According to the CDC, postpartum depression affects 1 in 9 mothers in the
United States3.
Vitamin D deficiencies have been found to be significantly correlated with depression,
however there is little research regarding the biochemical mechanism4. Some studies have noted
that vitamin D receptors are found in the areas of the brain that also produce key hormones and
related enzymes important to neuroimmunomodulation, neurodevelopment, and overall brain
function4. Other studies have found that vitamin D is protective against Alzheimer’s disease and
other neurodegenerative diseases1. The exact mechanism is still a significant area of research in
the future.
Numerous other studies have found significant vitamin D deficiencies in pregnant women
compared to nonpregnant women. 5One possible reason for vitamin D deficiencies in pregnancy
is proposed by Gur et al6: because the fetus gains its own vitamin D from the mother, umbilical
cord blood vitamin D levels have been found to correlate well with maternal vitamin D. Also,
Narchi et al7 found in their longitudinal study on maternal vitamin D status that throughout
pregnancy and lactation (postpartum) there is a steady decrease in serum vitamin D levels. In
order to elucidate the complex mechanism of postpartum depression, this relationship has been
investigated in recent years8. Because of the multifactorial nature of this disorder, numerous
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demographic variables are considered potential confounders in the following studies. In this
review, I aimed to include the most relevant methods and data points for analysis. Complete
methodology and data analysis can be found in the cited sources.
Natural sources of vitamin D include exposure to sunshine and some foods, including
fatty fish. Vitamin D from these sources must then be metabolized into calcidiol (25-OH-D) in
the liver then to its active form, calcitriol, by the kidneys. The form of vitamin D referred to in
this paper and all the following studies is specifically vitamin D3. According to the NIH, the
recommended daily allowance (RDA) for vitamin D for women of childbearing-age (19-50
years) is 600IU/day. For pregnant and lactating women, it is also 600IU/day. Papers were
included in this review if there was at least one measurement of depression post-delivery as well
as a vitamin D measurement or supplemental intervention at any point during or after pregnancy.
Papers were also limited to those available in English. A total of 15 studies were identified that
fulfilled these requirements.
Although perinatal depression studies are included, in this review, the objective will be
analyzing depression data taken after delivery.
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Literature Review:
Abedi and colleauges9 performed a cross-sectional study in Izeh, Iran, a city in the
northeastern part of the country to analyze differences in 25-dihydroxy vitamin D (25-OH-D)
serum levels in 120 postpartum women. Eligible participants were 18-35 years old and 6-8
weeks postpartum. 60 women with postpartum depression and 60 women without postpartum
depression were selected. Participants were also matched to account for age and vitamin D
supplementation. Depression was measured using the Beck Depression Scale10, which included
21 questions and quantified results on a scale from 0 (no depression) to 3 (severe depression).
Various demographics and patient histories were taken including breastfeeding, number of
pregnancies, and mode of delivery. Venous blood was drawn for determining levels of 25-OH-D,
and participants were then classified into groups according to serum levels. Normal was
classified as 25-OH-D>30ng/ml, mild deficiency as 20-30ng/ml, moderate deficiency as 1020ng/ml and severe deficiencies as <10ng/ml.
Participants with postpartum depression had a higher body mass index (BMI) than
women without depression, though not significantly. No significant difference was found
regarding mode of delivery, breastfeeding, abortion history, and number of pregnancies. A
nonsignificant difference was found between sunlight exposure between the two groups: women
with postpartum depression had less exposure (9 ± 13.01min/week) compared to women without
depression (10.53 ± 13.86min/week). There was a significant difference in vitamin D levels
between women with and without depression: women with depression had a mean vitamin D
level of 16.89 ± 7.05ng/ml whereas women without depression had levels of 21.28 ± 7.13
(P=.001). The majority (53.3%) of women with postpartum depression were found to have a
moderate vitamin D deficiency while the majority of women without postpartum depression
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(50%) were found to have a mild deficiency. After odds ratio (OR) analysis, it was found that
women with 25-OH-D<20ng/ml were 3.30 times more likely to report depression than women
with D>20ng/ml. Women in good economic situations and whose last pregnancy was desired
were less likely to be depressed (P= 0.054 and P=0.02, respectively).
A weakness of the study includes lack of longitudinal data for the participants. No data
was gathered regarding the serum vitamin D levels or depression symptoms during pregnancy.
The authors noted in their discussion that vitamin D deficiency has been found to be more
prevalent in Iranian women. Based on their data, the authors concluded that women with a severe
vitamin D deficiency were twice as likely to have postpartum depression within 6-8 weeks of
giving birth. They recommend that testing vitamin D levels in pregnant women be a standard test
in order to proactively prevent consequential postpartum depression.
In 2015 a prospective study was published by Accort et al11 to determine whether
prenatal serum 25-OH-D status was related to postpartum depression and if inflammatory
cytokines during the prenatal period were involved in the development of postpartum depression.
Secondary data were used from previous investigations by Cassidy-Bushrow et al12,13 published
in 2012. Eligible participants were 18-44 years old and in their second trimester of pregnancy.
Participants with very morbid obesity were excluded (BMI>60kg/m2)14. African American
women were recruited from health centers in Detroit, Michigan who had had serum 25-OH-D
levels measured in their first trimester. Serum vitamin D data were collected from patients’
medical records. Inflammatory cytokines were measured from a blood draw during the second
trimester. The inflammatory biomarkers assessed were high-sensitivity C-reactive protein (hsCRP) as well as various interleukins: IL-1b, IL-6, IL-10, and TNF-a. Because levels for IL-1b
and TNF-a were below the Limit of Detection (0.1mg/ml) in greater than 20% of the sample,
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results for these two markers were not reported. CES-D (Center for Epidemiological StudiesDepression)15 scores were gathered by Cassidy-Bushrow and colleagues during the antenatal
period, and this data was used in the Accort et al study as a continuous variable for regression
analyses. Various demographic characteristics were also measured. For postpartum depression
scores, only participants who had a postpartum checkup in which depression screening occurred
were included in the investigation by Accort et al Postpartum depression was assessed using the
Edinburgh Postnatal Depression Scale (EPDS)16. 91 African American women fit the eligibility
criteria and were included in the analysis by Accort et al.
Participants’ average age was 26 years old. The average BMI was 29.2, and the majority
of women were overweight or obese (N=58). Histories of depression, hypertension, and preterm
birth were low (7%, 9%, and 9%, respectively). The majority of participants were unmarried
(75%), had a high school diploma (58%), and were currently employed (63%). Preterm birth
(<37 weeks’ gestation) occurred for 6 of the 91 women. A total of 85 women had been excluded
because of a lack of postpartum EPDS scores. Their data was compared to the 91 women who
were included in the study to assess differences in maternal age, 2nd trimester CES-D scores,
preterm birth, vitamin D levels, and inflammatory cytokine levels. No significant differences
were found in any of these measures (P>0.05). Regression analyses were performed in order to
determine any relationships among vitamin D levels, inflammatory markers, and postpartum
depression. In regression analyses adjusted for covariates, the log 25-OH-D levels were
associated marginally with EPDS scores (P=0.058). However, in unadjusted analyses there was
no significant association (P=0.172). There was no significant association found between any
one inflammatory marker and postpartum depression. However, it was found that IL-6 and the
IL-6/IL-10 ratio both significantly interacted with serum 25-OH-D levels and its association with
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postpartum depression (P=0.025 and P=0.016, respectively). It was also found that in
participants with higher Il-6/IL-10 ratios, more depression symptoms were reported. The authors
also noted that their findings remained after controlling for prenatal depression from the CES-D
scores. Although, only a marginally significant association was found between serum vitamin D
levels and postpartum EPDS scores (P=0.058), the authors concluded that women with higher
inflammatory cytokine levels (IL-6 and IL-6/IL-10 ratio) as well as low vitamin D levels
reported greater postpartum depression symptomology. The authors suggest that the higher
cytokine levels could be penetrating areas of the brain affecting neurotransmitters in mom and
leading to depressive symptoms in the future. One strength of the study was the analysis of
women both prenatal and postpartum. However, the authors note that in general, African
Americans have been found to have higher risk of vitamin D deficiency and inflammation,
limiting the applicability of the findings. The authors suggest similar studies specifically
analyzing synergistic interactions among vitamin D, inflammatory markers and postpartum
depression in a larger sample.
Fu et al17 conducted a study in China that analyzed correlations between postpartum
serum 25-OH-D levels and prevalence of postpartum depression in 213 Chinese women. The
duration of the study was from August of 2013 to November 2013 in a hospital in Beijing,
China. Eligible participants were women who had given birth at full term (≥37 weeks’ gestation),
to a single, live-born infant. Participants were excluded if they had any history of psychiatric
care during pregnancy, confidential personal information, or whose infant was admitted to the
neonatal intensive care unit directly after delivery. Fasting blood samples were collected from
the mothers before they left the hospital but after some recovery time: 24-48 hours after birth.
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Three months later, the women returned for a postpartum check-up which included a Chinese
version of the EPDS. Various baseline characteristics were also collected at enrollment.
The median age of the sample was 31 years. The majority of participants were considered
middle class (55.9%). Women were not excluded based on mode of delivery – 60.6% of
participants had a vaginal delivery. Depression occurred before or during pregnancy for 5.6% of
the participants. The ethnicity of 91.1 percent of the participants was Han Chinese. Other data
collected included breastfeeding rate, stressful life events, whether the pregnancy was planned,
and partner support. It was found that 82.6% of the participants were vitamin D deficient,
categorized as <20ng/ml. The median serum 25-OH-D level was 13.8ng/ml and no significant
difference was found in samples taken in different months. A weak negative correlation was
found between serum vitamin D levels and postpartum symptomology (r=-0.293, P<0.0001).
After adjusting for confounding variables such as breastfeeding, stress, partner support and
others, the association using linear regression was still significant. Of these, depression before or
during pregnancy, stressful life events, and decreased partner support were found to be predictors
of postpartum depression. 25-OH-D levels showed a strong association with EPDS scores with
an unadjusted odds ratio of 0.74. An increased risk of postpartum depression symptomology was
associated with vitamin D levels ≤10.2ng/ml in multivariate analysis after adjusting for all
confounders. One noted weakness of this study included the single blood sample for vitamin D
analysis. The authors stated it would be helpful to observe changes in vitamin D levels from
prenatal to a few months postpartum.
Another postpartum blood and depression study was performed by Gould et al18 and
published in 2015. For this study cord blood 25-OH-D levels were analyzed immediately
postpartum for possible association with postpartum depression. The data for this study was
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collected from a previous randomized control trial in 2010 studying the effects of omega-3 fatty
acid DHA supplementation on postpartum depression by Makrides et al19 Eligible participants
were recruited at less than 21 weeks’ gestation for singleton pregnancies. Exclusion criteria
included not having a cord blood vitamin D analysis done, giving birth at <20 weeks’ gestation,
already taking DHA supplementation or participating in another fatty acid study, and having
previous history of drug or alcohol abuse. Women were randomly assigned to the treatment or
placebo group. Those in the treatment group were told to take three 500mg/day DHA-rich fishoil supplements. The control group was told to take three 500mg/day capsules of vegetable oil.
The authors stated that there was no vitamin D in the fish-oil or vegetable oil capsules.18
Supplementation was done from day of entry until day of delivery. On the day of delivery, cord
blood samples were taken and analyzed for levels of serum vitamin D. Depression screening was
performed through administration of the EPDS at two time points: six weeks and six months
postpartum.
Demographics were collected as well as possible confounders including maternal age,
race, parity, BMI, history of depression, and supplement use during pregnancy. Cord blood
samples were collected from 1040 women. The majority of both the DHA treatment group and
control group had 25-OH-D levels of >50nmol/L. Other levels of vitamin D were <25nmol/L
and 25-50nmol/L. The authors stated that these could not be used to determine maternal vitamin
D sufficiency or insufficiency due to the fact that cord blood vitamin D is generally lower than
maternal blood. Demographic and lifestyle characteristics were taken from all of the participants
so there remain significant holes in the collected data. At least 24.5% of women were taking
dietary supplements at baseline. Seasonal changes in potential vitamin D exposure were
accounted for before analysis. Overall, there was no significant association between cord blood
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vitamin D and postpartum depression at six weeks or six months (P=0.11 and P=0.41,
respectively). Treatment group did not affect these findings. However, women in the control
group at six weeks postpartum were less likely to report depression symptoms if their serum
vitamin D levels at delivery were >50nmol/L compared to control participants with vitamin
D<25nmol/L (P<0.001). The authors concluded that evidence was inconsistent concerning the
mediation of postpartum depression by vitamin D levels at delivery. One weakness of the study
is the lack of control on external dietary supplementation by the participants. Because this study
was a secondary analysis, that data was not available, and the possibility of alternative vitamin D
supplementation before, during, or after delivery remains a confounder. Another weakness is the
incomplete demographic and lifestyle data gathered at baseline. One major strength of this study,
however, is the large sample size.
Gur and colleagues6 published a study out of Sifa University in Turkey investigating the
association between vitamin D levels during mid-pregnancy and postpartum depression.
Participants were pregnant women at 24-28 weeks’ gestation from a hospital in Izmi, Turkey.
Inclusion criteria were relatively strict. Eligible participants were married, Caucasian women of
18-40 years old with a desired or planned singleton pregnancy. They also were of BMI 2030kg/m2, had 8 or more years of education, of parity of ≤3, receiving an annual income of
≥$4500 USD, nonsmokers, nondrinkers, without an unknown psychiatric or medical disease, and
a native Turkish speaker. The purpose of these criteria were to exclude participants prone to
postpartum as established by previous investigations 20-21. 208 women were enrolled in the study,
and blood samples were collected, and serum 25-OH-D levels were determined. After giving
birth, 19 women were excluded from the study due to various complications with the delivery.
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179 women completed the study through final data collection. To measure depression
symptomology, participants completed the EPDS at 1 week, 6 weeks and 6 months postpartum.
Demographic statistics were calculated from the 208 enrolled women. The mean age was
28.5 years and the mean BMI was 26.5 for this group. The mean gestation age of vitamin D
sampling was 25.2 weeks. The majority of participants were taking vitamin D supplements of
400IU/day (84.6%) and 7.6% of participants were taking 1200IU/day regularly (≥3 times per
week). The remaining 7.6% did not report taking any vitamin D supplements. It was found that
11% of the women had a severe vitamin D deficiency (≤10ng/ml), 40.3% had a mild deficiency
(10-20ng/ml), and 48.5% showed normal levels of serum vitamin D (≥20ng/ml). One week after
delivery, 21.1% of women were defined as EPDS ≥12. At six weeks’ postpartum 23.2% had
postpartum depression, and at 6 months 23.7% had postpartum depression. At each of the three
EPDS screening time points, a significant negative correlation was found between serum 25-OHD levels and EPDS scores (r= -0.2, -0.2, -0.3, respectively). There was also a significant
difference found in mean vitamin D levels between women with and without postpartum
depression at all time points (P=0.003, 0.004, <0.001, respectively). The difference in mean
EPDS scores between women with normal vitamin D levels and severe or mild deficiencies was
also significant at all time points (P=0.002, <0.001, 0.001, respectively). The authors concluded
that low maternal vitamin D status at mid-pregnancy was associated with prevalence of
postpartum depression at 1 week, 6 weeks and 6 months postpartum in this study. Secondary
conclusions included determining that vitamin D deficiencies were prevalent in a large portion of
the sampled population, even as analyses were performed during summer and autumn. It was
also noted that some significant weaknesses of the study include its small sample size, lack of
vitamin D level analyses throughout pregnancy, and lack of moderation of results due to serum

Vitamin D and Postpartum Depression

13

sampling during the summer and autumn seasons. Upon review of this study, I had wished to see
a baseline depression score taken antenatal. Though this would have added more complexity to
the data, it would have given insight into its association with postpartum depression. Although
women with psychiatric diseases were excluded, depression is considered a disorder, not a
disease.22 Moderating for this affect would effectively manage this possible confounder.
Lamb and colleagues23 conducted a cohort study on the association between vitamin D
deficiency and depression in the perinatal period. Similar to the study by Gould et al 18, blood
25-OH-D levels were determined from samples of cord blood. However, maternal blood vitamin
D levels were also collected in order to analyze relationships between these two blood sources
and maternal depression. Participants were recruited from a hospital in California where they
were receiving prenatal care. Eligible participants were pregnant women at <25 weeks’ gestation
and at least 18 years old. Exclusion criteria were defined by the following: 1) parathyroid
disease, 2) uncontrolled thyroid disease, and 3) severe mental illness other than depression. 125
of enrolled women completed the study through data collection. Data was collected at three time
points. In early pregnancy (mean=14 weeks estimated gestational age (EGA)), women selfreported demographic information, took the EPDS, and provided a blood sample for serum
vitamin D analysis. Delivery was timepoint 2 (T2); women took the EPDS, gave maternal blood,
and had a cord blood sample taken. Timepoint 3 was on average 10 weeks postpartum. Women
took the EPDS again and gave another maternal blood sample. Along with demographics,
women reported if their pregnancy was planned and any current medications or supplements.
Depression was defined as an EPDS score of ≥15 and blood 25-OH-D deficiency was
defined as <20ng/ml. Mean age of participants was 33.2 years and mean BMI was 26.6kg/m2.
21.6% of women had vitamin D deficiencies at baseline, and the majority were married or living
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with a partner (95.2%). 73.6% of their pregnancies were planned, and the mean EGA at time of
birth was 37.7 weeks. Family history of depression was reported by 20% of participants and
personal history of depression of the mother was reported by 8.8%. Vitamin D supplementation
was taken by 9.6% of participants and their mean dosage was 508.3IU/day; there was an increase
(7.4ng/ml) in serum vitamin D levels between T1 and T2 in these women compared to the whole
sample. Differences in EPDS scores among all time points were not significant (P=0.19). Serum
vitamin D levels at T1 and EPDS at T3 (postpartum) were correlated with a coefficient of -0.23
(P<0.05). There was no significant correlation between EPDS T3 and vitamin D at T2. Vitamin
D T3 and EPDS T3 were significantly correlated with a coefficient of -0.22 (P<0.05). Lamb et al
concluded from their investigation that vitamin D demonstrates a significant inverse relationship
with antenatal and postnatal depression. However, they were not able to draw conclusions on the
direction of the association. One weakness in the data was the lack of control for family
depression history and personal depression history as a confounder for postpartum depression
scoring. The authors did control for family depression history only for the relationship between
baseline EPDS and baseline vitamin D.
In 2013, Leung et al published a study out if the University of Calgary studying the
association between micronutrient supplementation and postpartum depression. This cohort
study collected information on the current supplementation habits of 600 pregnant women. These
participants then took the EPDS at least twice during pregnancy and 12 weeks postpartum.
Participants were taken as a sample from the APrON (Alberta Pregnancy Outcomes and
Nutrition) study which was going on concurrently. Eligible women were at least 16 years old at
≤27 weeks’ gestation. Women were excluded if they did not speak English, were a known drug
or alcohol abuser, or were planning to move to a difference region within 6 months of screening.
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At enrollment, women completed demographic and lifestyle characteristics. Women provided
information on their current supplementation habits (frequency and dose) 2-3 times during
pregnancy.
The supplements analyzed were limited to vitamins, minerals, and fatty acids; data was
taken on a broader category which included herbal products, amino acids, homeopathic
remedies, and traditional medicines, overall referred to as natural health products (NHP). Data
was taken on 475 women who completed all data collection points. Depression was determined
as an EPDS score of ≥10. Demographic characteristics were associated with the EPDS scores of
<10 or ≥10 at their postpartum screening. The mean age of women with EPDS<10 was 31.2 and
for those with EPDS≥10, mean BMI was 31.6 with no significant difference between the groups.
Mean BMI for women with and without postpartum depression were 24.1 and 24.2, respectively
with no significant difference. The mean vitamin D supplementation taken by women without
postpartum depression was 618IU/day and the mean for women with postpartum depression was
567IU/day (P=0.48). Of women who were taking below the Recommended Dietary Allowance
of vitamin D, 12.3% had postpartum depression. RDA values were taken from the Institute of
Medicine24. Vitamin D levels were not found to be a predictor for postpartum depression
(OR=1.00, P=0.92). The authors concluded that patients consuming vitamin D at less than the
RDA were more likely to have EPDS≥10 postpartum. However, it was not found to be a
significant predictor of postpartum depression. One limitation was reliance on recall and selfreporting of supplement use by the participants. Another major limitation identified in the study
was the lack of serum concentration data for any of the nutrients studied. Therefore, the authors
were unable to relate supplementation to biological vitamin D levels. Overall, the data does not
show that vitamin D supplementation is a predictor of postpartum depression.
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Another study investigating nutritional status and postpartum depression symptoms was
performed by Lin and colleagues25, specifically on its association with postpartum nutritional
status. Participants were women at a Taiwanese hospital who returned for a postpartum checkup
from 6-8 after delivery. Recruitment occurred from January of 2016 to September 2017. Women
were excluded for smoking, drinking alcohol, preterm delivery, mental disorder diagnosis
(including depression), acute infection, congenital diseases, parity greater than 1, and if the
infant born had any diseases. At the postpartum checkup, participants took the Chinese version
of the EPDS. Scores ≥10 were defined as present postpartum depression. Various demographic
and lifestyle characteristics were also taken at this timepoint. These included traditional
postpartum confinement and breastfeeding status. Nutritional levels were determined form a
venous blood sample taken at the postpartum checkup.
A total of 120 participants completed all data collection. Postpartum depression was
present in 80.8% of the sample. The mean age of this group was 32.6 and the mean BMI
postpartum was 23.4. For the group without confirmed postpartum depression, the mean age was
31.6 and mean BMI was 21.5. There were no significant differences in any of these variables
between the two groups. Significant differences were found between these two groups regarding
lack of family support, lack of husband support, financial stability, psychological stress, and
postpartum care satisfaction. Nutritional biomarkers analyzed included hemoglobin, ferritin,
vitamin D (25-OH-D), and riboflavin. Mean vitamin D levels in the non-postpartum depression
group was 24.0ng/ml and for the postpartum depression 26.3ng/ml. There was no significant
difference in vitamin D between these two groups (0.197). Correlations between nutritional
metrics and EPDS scores were also done with and without adjustment for covariates. Covariates
included postpartum confinement, psychological stress, and postpartum care satisfaction. There
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were no significant relationships found between prevalence of postpartum depression
symptomology and serum 25-OH-D levels without or with adjustment (P=0.198 and P=0.352,
respectively). Though the authors found that there was a high prevalence of vitamin D
insufficiency and deficiency in their sample, there was no evidence of an association with
postpartum depression. Some key weaknesses identified by the authors was the lack of
longitudinal data, specifically on vitamin D levels and small sample size.
Murphy et al26 performed a prospective cohort study analyzing the correlation between
serum 25-OH-D levels and concurrent postpartum depression symptomology in women who
were a part of a larger cohort study involving vitamin D supplementation. Women completed
demographic questionnaires, the EPDS, and gave a sample of venous blood once a month for the
first seven months after delivery. Eligible women were 18-45 years old and participating in a
concurrent study at Medical University of South Carolina. They delivered at least 35 weeks’
gestation and were 4-6 weeks postpartum at first visit. Women were excluded if their deliver was
not a singleton, had existing diabetes, hypertension, parathyroid or uncontrolled thyroid diseases.
EPDS scores of <9 defined an absence of postpartum depression. A score of ≥9 was used to
define postpartum depression. Demographic information included infant feeding method, season
of the visit, and marital status. Vitamin D status was defined as deficiency, insufficiency, and
sufficiency (<20ng/ml, 20-32ng/ml, and >32ng/ml, respectively).
Data was collected on 97 participants, all of whom were found to be taking vitamin D
supplements of at least 800IU/day. Statistical analysis was adjusted for demographic and clinical
characteristics that could be confounders. Women with sufficient vitamin D were more often
married, more educated and had a planned pregnancy that those with insufficient vitamin D
levels at baseline. Adjusted EPDS scores were significantly lower for the group with sufficient
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vitamin D levels than those without (P=0.02). Unadjusted EPDS scores maintained this
relationship over all seven timepoints. There was also a significant negative relationship between
EPDS scores and being unmarried. Significant positive relationships existed between EPDS
scores and breast-feeding. The authors concluded that vitamin D deficiency or insufficiency
postpartum is a potential risk factor for women developing postpartum depression. The authors
noted that routine screening for vitamin D levels could not be recommended until a similar study
was performed with a larger sample and yielded similar results. One noted strength of the study
is the longitudinal tracking of vitamin D levels and postpartum depression trends over time for
mothers. One weakness that I observed in this study was the lack of control for women who had
family or personal histories of depression.
In 2013, Nielsen et al27 published a study on the relationship between vitamin D status
during pregnancy and rates of postpartum depression. This was a case-control study nested in the
Danish National Birth Cohort study. Serum 25-OH-D levels were measured in late pregnancy
and correlated with postpartum depression. Women were recruited between 1996 and 2002.
Eligible participants were Denmark-born, had a singleton, live birth, and had given a blood
sample in late pregnancy (~25 weeks’ gestation). Women in the case group had filled a
prescription for anti-depressant medication within one year of delivery but were never
hospitalized for postpartum depression. Eligible women for the control group were selected
randomly from this same sample in such a way as to represent the maternal age and delivery year
distribution of the case group. Women were excluded if they had ever been diagnosed and
recorded has having any mental illness before pregnancy or using antidepressants within a year
before delivery. Confounders that were identified included BMI, social support, smoking,
multivitamin use during pregnancy, and socioeconomic status (SES). Vitamin D levels were
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identified in six levels of nmol/L: <15, 15-24, 25-49, 50-79, 80-99, and >100. Odds ratios were
calculated for differences in the number of women with a particular vitamin D concentration
between cases and controls.
Data was collected from 605 women in the case group and 875 women in the control
group. Odds ratios between confounding variables were calculated in order to discover any
significant differences in these factors between the 2 groups. There were significant differences
found regarding social support, parity, SES, and smoking status during pregnancy. The median
vitamin D status for the whole sample was found to be 55.62nmol/L. This is within the sufficient
range according to the Danish National Board of Health (50-79nmol/L). Odds ratios were
calculated with various adjustments for confounders. When only adjusted for maternal age and
year of delivery, no significant difference was found between the two groups. However, when
adjusted for further variables (+season, gestation week, parity; +smoking, SES, BMI, physical
activity, social support; +multivitamin supplementation) significant differences were found
(P=0.03, 0.08, and 0.08, respectively). The authors noted that vitamin D binding protein may
have played a role in these results as it affects the availability of serum 25-OH-D. Controlling for
this variable is noted as a point of further study. A main strength in the procedures of this study
identified by the authors was the biological measurement of vitamin D levels as opposed to
recording supplementation, in which it is difficult to control for food intake. Another strength is
the large sample. However, the lack of a controlled determination of depression is a limitation
because of potential for inaccurate diagnoses. Also, women could have experienced postpartum
depression but never sought a medical consultation or filled in a prescription.
Paoletti and colleagues 28 performed a study in Italy that administered supplements for
postpartum women in a randomized controlled trial. The goal of this study was to determine the
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efficacy of the supplement Elevit® on mood in postpartum women. Postpartum women who
recently had their first full-term delivery (within 3 days) were eligible to participate. Eligible
women were 20-40 years old, BMI between 22-26kg/m2, had a spontaneous delivery at 37-41
weeks’ gestation to a healthy baby (determined as an Apgar score 9-10 within 5 minutes). Low
hemoglobin levels, delivery by Cesarean section, and personal or familial history of or current
psychiatric or mental illness were some exclusion criteria. At the first visit (3 days after
delivery), women were enrolled, completed the EPDS, gave a venous blood sample, and were
randomly assigned to a treatment group. The first group (defined as group A) was given a
treatment regimen of daily oral tablets of Elevit®, the second group (group B) received a tablet of
Orotre®, a vitamin D and calcium supplementation of 400IU and 500mg, respectively. The
second visit was approximately 15 days after delivery and the final visit was 30 days after
delivery. At each follow-up visit, a blood sample was taken, and women completed the EPDS.
An EPDS score of greater than 12 indicated significant depressive symptoms. The blood samples
were analyzed for hemoglobin, iron, and ferritin levels.
Five hundred and fifty-two women completed the study through the third follow-up visit:
274 in group A and 278 in group B. The mean BMI for group A and group B at baseline were
23.9 and 24.0, respectively. At baseline, 85.7% of participants had EPDS scores<12. There was
no significant difference in EPDS scores between the two groups at this first timepoint. There
was a significant decrease in EPDS scores in both groups (regardless of baseline EPDS score) for
both groups. However, the decrease was significantly larger for group A (P<0.05). Elevit®,
administered to group A, contains vitamins A, B1, B2, B6, B12, C, D (500IU), and E as well as
biotin, folic acid, and various minerals. Compared to Orotre®, Elevit® contains 100IU more in
each dose. One weakness of the study is the lack to data on serum vitamin levels to determine the
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biological effects each supplement. With this data, a correlation between vitamin levels and
EPDS scores could be calculated. This study is still valuable as it is one of the few randomized
control trials to include vitamin D interventions and postpartum depression measurements.
Robinson and colleagues 29 performed a correlational study in Australia with a subset of
women enrolled in the Western Australian Pregnancy Cohort (Raine) Study30. Venous sera
measurements of 25-OH-D were taken antenatal (around 18 weeks’ gestation) and demographic
characteristics were recorded. At three days post-delivery, participants took a variation of the
EPDS. Eligible women were at 18 weeks’ gestation and Caucasian. Full enrollment details were
not cited in the study by Robinson et al29, they can be found in the work by Newman et al31
(1993). An EPDS score of ≥10 was determined to indicate possible mood disturbances.
Sera were collected from 796 women, and postpartum depression symptomology data
also collected for 706 women. No specific demographic data is given in the study for the sample.
However, the authors did adjust analyses for a number of characteristics including BMI,
smoking, alcohol use, season of birth, and maternal age. There was a significant relationship
found between postpartum depression symptoms and low vitamin D levels (P=0.017). Smoking
during pregnancy was also found to be correlated with low vitamin D levels (no P-value given).
Women with a vitamin D concentration of <47nmol/L were significantly more likely to develop
postpartum depression symptoms than women with vitamin D >70nmol/L (OR=2.19). One
weakness of this study is the lack of reporting on demographic characteristics. This prevents the
possibility of secondary analysis on the given confounding variables. Another weakness is the
single assessment of postpartum depression as opposed to multiple measurements over a longer
period of time. However, the adjustment of the many confounding variables strengthens the
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findings. Although requiring participants to be Caucasian controlled for melanin and vitamin D
skin absorption, it also made the findings less generalizable.
Rouhi et al published a double-blind, randomized, controlled clinical trial in 2018 that
analyzes the effect of vitamin D supplementation on postpartum depression in Iranian women.
Participants were recruited at approximately 4 months’ postpartum. Some inclusion criteria were
vaginal birth, no history of psychiatric disorders, and breastfeeding. Women then took the EPDS
and Fatigue Identification Form (FIF). Participants were randomly assigned to a treatment or
placebo group if they had EPDS≥13 and FIF≥20. The treatment group received pills of 1000IU
vitamin D and the control group was given similar placebo pills. All participants were assigned
to take one pill daily for the next 6 months. Participants were also told not to take any outside
supplements during this time period. Six months later (10 months’ postpartum), participants took
the EPDS again.
Eighty women completed the study through final assessments. There were no significant
differences in demographic characteristics between the two groups at baseline (age, rate of
vaginal delivery, unplanned or complicated pregnancy, marital problems, and obesity). The mean
age was 24.7. There was also no significant difference in EPDS scores between the two groups at
baseline (P=0.484). The treatment group showed significant decreases in depression compared to
the placebo group (P<0.001). Some other predictive factors that were not addressed include
family and social support, lifestyle, and parity. One weakness of the study is the lack of blood
sampling for vitamin D deficiency measurements. It was also a relatively small trial. The
participants were also selected by convenience sample at certain health centers. Although no
significant differences were found in demographic characteristics, these values were not reported
in the study.
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Vaziri and colleagues 32 performed a single-blind randomized clinical trial in Iran to
assess the effect of vitamin D supplementation on perinatal depression. Eligible participants were
pregnant women 18 years’ or older with no history of mental illness. They were also 26-28
weeks’ gestation and scored 0-13 on a baseline EPDS assessment. After enrollment, participants
were randomly assigned to either the treatment or placebo group. Each group received pills to
take daily until childbirth. The treatment group received supplements of 2000IU/day of vitamin
D. Serum 25-OH-D levels were measured at two timepoints: baseline and childbirth. Depression
was assessed with the EPDS at baseline, 38-40 weeks’ gestation, and 4-8 week’s postpartum.
136 women completed the study through final timepoints.
There was no significant difference between the two groups at baseline in age, education,
parity, or sun exposure. However, there was a significant difference at baseline in use of other
supplement and whether the pregnancy was planned. (P=0.017, and 0.01, respectively). The
mean baseline vitamin D levels was 12.35ng/ml. Vitamin D deficiency was defined as <20ng/ml
and was found in 87.6% of participants at baseline. There was no significant difference in
vitamin D levels between the two groups at baseline. The difference in mean depression scores
was not significant different between participants with vitamin D <20ng/ml and those with
vitamin D≥20ng/ml. A significant difference was found between those with vitamin D deficiency
and sufficiency in sun exposure at baseline (P=<0.001). At delivery, a significant difference in
vitamin D levels was found (P=0.001). At 38-40 weeks’ gestation there was a significant
difference of P=0.01 found between the treatment and control group in depression scores.
Depression scores were also significantly different between the two groups at 4 weeks and 8
weeks postpartum (P=<0.001 for both). No correlation was found between change in vitamin D
concentrations and change in depression scores at 380 40 week’s gestation or 4 and 8 weeks
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postpartum. Overall, this is a valuable clinical trial because of the controlled nature. It is also
strong because of the simultaneous intervention as well as measuring blood vitamin D levels at
multiple timepoints including antenatal. The major weakness of the study is the small sample
size.
Williams et al33 performed a secondary analysis of a randomized clinical trial
(Mozurkewich, 201134) that assessed the effect of omega-3 and fatty acids on depression in
pregnant women. Participants were recruited from October 2008 to May 2011 in Michigan.
Eligible women were pregnant and at risk for depression (past history of depression, postpartum
depression or EPDS score 9-19). Participants were also ≤18 years old, in a singleton pregnancy
of 12-20 EGA. Participants were excluded for reasons including current major depressive
disorder, bipolar disorder, and taking antidepressant medication. Enrolled women were randomly
assigned to either one of two fish oil supplement groups or a placebo group. The Beck
Depression Inventory (BDI) was used along with Mini International Neuropsychiatric Interview
(MINI)35 to assess depression at baseline, 26-28 weeks EGA, 34-36 weeks EGA, and 6-8 weeks
postpartum. Vitamin D levels in the blood were also taken at baseline and 34-36 weeks’
gestation. In the relevant study by Williams et al, vitamin D levels and BDI scores were analyzed
to find correlations. Low vitamin D was defined as <20ng/ml. For the secondary analysis, the
sample was separated into those with low vitamin D (<20ng/ml) and the rest of the group.
One hundred and five participants completed the whole study of the 126 that were
enrolled. Full demographic information is located in the parent study.34 The sample was 81.3%
white and the mean vitamin D level at baseline was 28.17ng/ml. There was a significant
correlation between vitamin D levels at 12-20 weeks’ and 34-36 weeks’ gestation (Pearson’s
p=0.60, P<0.001). Those with low vitamin D were significantly younger (P=0.03). There was no
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other significant difference found between these two groups at baseline. Vitamin D at 12-20
weeks was significantly predictive of BDI scores at 12-20 weeks’ and 34-36 weeks’ gestation
(P<0.05). Vitamin D levels at 34-36 week’s gestation did not predict participants’ BDI at the
same time point. However, there was no association between low vitamin D and postpartum BDI
in regression analyses and adjusting for confounding factors such as age, antidepressant use, and
BMI did not affect those results. Major depressive disorder was not associated with vitamin D
levels at any time point. Overall, the authors concluded that low vitamin D in early pregnancy is
predictive of more depressive symptomology in pregnancy but not postpartum. The strengths of
this study include its design as a prospective, longitudinal design, as well as measurement of
vitamin D levels at multiple time points. The other main strength is the diagnosis of depression at
all assessments through the MINI. However, the sample size is relatively small and the BDI was
used instead of the EPDS which is intended for pregnant and postpartum women. These
strengths and limitations are all identified in by the authors.
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Discussion:
Significant results pointing to a relationship between vitamin D and postpartum
depression are present in nearly all the analyzed studies. One key factor that should be
considered in the future is the effect of prenatal depression on postpartum depression. Though
there are a few studies that elucidate this relationship, more are needed. IF the relationship
remains confirmed, there is a need for future postpartum depression studies to include data on
antenatal depressive symptoms. Most of these studies controlled for histories of depression by
excluding participants with personal history, familial history, current depression, or even
multiple risk factors. This relationship would suggest that vitamin D status be tracked throughout
pregnancy and potentially even before pregnancy. Most studies identified the inefficiency of
routine screening for vitamin D insufficiency in pregnant women and recommended it be
instated6. From this review, such an action is supported as a preventative measure for both the
mother’s and baby’s subsequent health.
Depression measures used in these studies were EPDS16, CES-D15, BDI10, and MINI35.
The majority used EPDS because it pertains specifically to postpartum women. However, the
EPDS, CES-D and BDI questionnaires are not diagnostic tests for major depressive disorder as
they are only self-reporting. In person interviews with a trained clinician, like the MINI, are
required for a formal diagnosis. Only one study in this review included the MINI in its
depression assessments (Williams et al, 201633). More studies employing formal diagnostic
procedures would strengthen the findings on this relationship. Another limitation of the data
from the measures is the differing cutoffs of scores from depression measures. Most studies in
this review used the EPDS to identify depressive symptomology, however the cutoff for data
analysis differed across studies. The range of cutoffs for the EPDS was from 9-13.
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All of the studies measured vitamin D (specifically vitamin D3) in its form 25-OH-D.
Most studies controlled or adjusted for the season of pregnancy/birth because of its effect on
vitamin D from sun exposure. In other studies, the recruitment period is included. These studies
were performed in a wide variety of locations across the globe. Because of this, each of their
findings is minimally generalizable to other ethnicities. However, because significant positive
results have been found from multiple locations, they confirm each other. More studies are
needed that include a diversity of ethnicities, specifically melanin levels, in order to
systematically control for its effect on sun-sourced vitamin D while maintaining generalizability
of findings. A few studies took place in the Middle East.9,6,36,32 Most noted that women generally
have lower vitamin D levels compared to other regions of the world.37 One proposed reason is
that culture in the Middle East has women’s skin covered throughout the year possibly
preventing reception of vitamin D from the sun. Studies that specifically investigate the reason
for this disparity would be critical for determining effective treatment for this population.
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Conclusion:
Fifteen studies were identified that assessed postpartum depression at least once and
measured or intervened with vitamin D supplementation. Ten out of these studies found a
significant positive result indicating an effect of vitamin D levels or supplementation on
postpartum depression symptoms. This was with or without adjustment for confounding factors.
All 3 randomized control trials found positive results on the effect of the intervention. From the
following studies, it is concluded that vitamin D is a likely factor in the severity and presence of
postpartum depression. This review combined a number of different study types in order to
include all studies that investigated the relationship between vitamin D and postpartum
depression. Before more randomized control trials are performed for potential treatments, more
correlational studies with ethnically diverse samples and large sample sizes are needed to
confirm this relationship. Studies that use interviews like Williams et al33 and diagnose the
presence of depression are necessary to strengthen the results of assessments.
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